Oncology SupportNeutropenia ManagementBiopharmaceuticalsRecombinant Protein R&D
Biopharmaceuticals & Proteomics Lab
Developing indigenous biosimilar therapeutics and downstream protein purification technologies.
Evidence led
Validated methodology
CEMB quality
Research you can trust
Practical impact
From lab to real life
Trusted CEMB research & services
Why it matters
Scientific Significance & Real-World Value
Filgrastim is a recombinant form of granulocyte colony-stimulating factor (G-CSF), a protein that stimulates the bone marrow to produce white blood cells.
Developed through CEMB's biopharmaceutical research programme, it reflects the Centre's work on indigenous recombinant therapeutic proteins.
Evidence-led outcome
An indigenous recombinant protein developed to support white blood cell recovery, part of CEMB's biopharmaceutical portfolio.
Core Benefits at a Glance
Recombinant G-CSF protein
Supports white blood cell production
Developed through CEMB's biopharmaceutical research